Table 3 Comparison of patients’ clinical characteristics in the complete and partial neurological deficit recovery groups
Characteristics | Complete neurological deficit recovery (n = 7) | Partial neurologic deficit recovery (n = 4) | P value |
|---|---|---|---|
Age (years) | 49.1 ± 7.5 | 55.8 ± 2.4 | 0.648a |
Gender | 0.491b | ||
Male | 1 (14.3%) | 2 (50.0%) | |
Female | 6 (85.7%) | 2 (50.0%) | |
Time from symptoms and signs to treatment (days) | 5.0 ± 1.8 | 13.3 ± 6.3 | 0.164a |
Performance status (ECOG) | 0.491b | ||
< 2 | 2 (28.6%) | 0 (0.0%) | |
≥2 | 5 (71.4%) | 4 (100.0%) | |
Lactate dehydrogenase (IU/l) | 297.9 ± 32.6 | 286.3 ± 36.2 | 0.788a |
Extra-nodal involvement >1 site | 0.545b | ||
Yes | 3 (42.9%) | 3 (75.0%) | |
No | 4 (57.1%) | 1 (25.0%) | |
Stage | 1.000b | ||
1 | 3 (42.9%) | 1 (25.0%) | |
4 | 4 (57.1%) | 3 (75.0%) | |
International Prognostic Index score | 1.000b | ||
Low/low-intermediate | 3 (42.9%) | 1 (25.0%) | |
High/high-intermediate | 4 (57.1%) | 3 (75.0%) | |
Overall survival (months) | 43.8 ± 12.5 | 19.1 ± 4.1 | 0.412a |